Novo Nordisk A/S’s weight-loss and diabetes drugs are no longer in short supply, US regulators said, a decision that’s ...

A bipartisan group of U.S. state and territory attorneys general is pressing the FDA to take prompt action against those ...

A shortage of Danish drugmaker Novo Nordisk's popular weight-loss and diabetes drugs, Wegovy and Ozempic, has been resolved, ...

Novo Nordisk alleges Singaporean biotech KBP Biosciences made misleading statements before the two firms inked a licensing ...

A new generation of anti-obesity drugs aims for greater effectiveness, fewer side effects, and more convenience.

The latest investor updates on stocks that are trending on Friday.

Novo Nordisk is growing its India-based global business services to fill out vertical stacks, expand horizontal functions, ...

We recently published a list of the 12 Most Oversold Healthcare Stocks to Buy Now. In this article, we are going to take a ...

SINGAPORE: A local biotech company, which is being sued by Danish pharmaceutical company Novo Nordisk for suspected fraud, has had its global assets frozen.

More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.

Raising its price target on the shares to $21, reports The Fly, BofA nonetheless reiterated an "underperform" ( i.e., sell) ...

We recently published a list of 12 Best Global Stocks to Buy According to Hedge Funds. In this article, we are going to take ...